The challenge of breathlessness in the detection of pulmonary hypertension
Blasi F.
Eur Respir Rev 2012; 21: 1-3 |   |
The fifth world symposium on pulmonary hypertension will REVEAL the impact of registries
Humbert M.
Eur Respir Rev 2012; 21: 4-5 | |
How can we reduce the mortality of invasive pneumococcal disease?
Welte T.
Eur Respir Rev 2012; 21: 6-7 | |
REVEAL: a contemporary US pulmonary arterial hypertension registry
McGoon M.D., Miller D.P.
Eur Respir Rev 2012; 21: 8-18 | |
Pulmonary hypertension: the science behind the disease spectrum
Wilkins M.R.
Eur Respir Rev 2012; 21: 19-26 |  |
Risk factors for chronic thromboembolic pulmonary hypertension
Kim N.H., Lang I.M.
Eur Respir Rev 2012; 21: 27-31 | |
State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management
Jenkins D., Mayer E., Screaton N., Madani M.
Eur Respir Rev 2012; 21: 32-39 | |
How to detect disease progression in pulmonary arterial hypertension
Vachiéry J-L., Yerly P., Huez S.
Eur Respir Rev 2012; 21: 40-47 | |
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Margaritopoulos G.A., Romagnoli M., Poletti V., Siafakas N.M., Wells A.U., Antoniou K.M.
Eur Respir Rev 2012; 21: 48-56 | |
The remaining challenges of pneumococcal disease in adults
Ludwig E., Bonanni P., Rohde G., Sayiner A., Torres A.
Eur Respir Rev 2012; 21: 57-65 | |
Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years
Demoly P., Annunziata K., Gubba E., Adamek L.
Eur Respir Rev 2012; 21: 66-74 | |
Asymptomatic bilateral pulmonary embolism in Churg–Strauss syndrome
Maria A., Guilpain P., Forestier A., Delhom E., Schiffman A., Rivière S., Van Kien A.K., Leray-Moragues H., Serre I., Vincent T., Eliaou J-F, Le Quellec A.
Eur Respir Rev 2012; 21: 75-77 | |
Pulmonary Circulation: Diseases and their Treatment. 3rd Edition.
Farber H.
Eur Respir Rev 2012; 21: 78 | |